Lethargic
发表于 2025-3-26 21:32:41
http://reply.papertrans.cn/28/2790/278959/278959_31.png
高原
发表于 2025-3-27 02:58:46
http://reply.papertrans.cn/28/2790/278959/278959_32.png
支架
发表于 2025-3-27 07:00:40
http://reply.papertrans.cn/28/2790/278959/278959_33.png
appall
发表于 2025-3-27 09:54:34
http://reply.papertrans.cn/28/2790/278959/278959_34.png
善变
发表于 2025-3-27 15:51:11
Which Patients Benefit from Biologic Agents to Prevent Disease Recurrence After Resection in Crohn’sot curative and clinical recurrence and repeat surgery is not uncommon. Novel immunosuppressive therapies including biologics are effective in reducing the risk of postoperative recurrence. We review the evidence focusing on risk factors for postoperative recurrence to clarify which patients benefit
画布
发表于 2025-3-27 20:08:16
http://reply.papertrans.cn/28/2790/278959/278959_36.png
bonnet
发表于 2025-3-27 23:35:18
http://reply.papertrans.cn/28/2790/278959/278959_37.png
管理员
发表于 2025-3-28 04:11:03
http://reply.papertrans.cn/28/2790/278959/278959_38.png
不适
发表于 2025-3-28 09:16:36
http://reply.papertrans.cn/28/2790/278959/278959_39.png
物质
发表于 2025-3-28 13:47:35
http://reply.papertrans.cn/28/2790/278959/278959_40.png